Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
Neuropharmacology|April 23, 2013
Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington's diseaseRobert B Laprairie, Melanie E M Kelly, Eileen M Denovan-Wright
Methods in Molecular Biology (Clifton, N.J.)|April 11, 2019
Combining SRET2 and BiFC to Study GPCR Heteromerization and Protein-Protein InteractionsAmina M Bagher, Melanie E M Kelly, Eileen M Denovan-Wright
The Journal of Physiology|March 3, 2007
Proton modulation of ion channels in isolated horizontal cells of the goldfish retinaMichael G Jonz, Steven Barnes
Neurourology and Urodynamics|August 5, 2021
Rodent models of ketamine-induced cystitisSaki Sultana, Geraint Berger, Ashley Cox, et al.
Journal of Basic and Clinical Physiology and Pharmacology|February 6, 2013
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gutMandana Kianian, Nadia A Al-Banna, Melanie E M Kelly, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 21, 2011
Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressureAnna-Maria Szczesniak, Yehoshua Maor, Harold Robertson, et al.
Health & Social Care in the Community|May 7, 2022
Enhanced supported living for people with severe and persistent mental health problems: A qualitative investigationSteven Barnes, Jerome Carson, Kevin Gournay
Molecular Pharmacology|December 25, 2015
Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington DiseaseRobert B Laprairie, Amina M Bagher, Melanie E M Kelly, et al.
Molecular Pharmacology|April 8, 2016
Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection NeuronsAmina M Bagher, Robert B Laprairie, Melanie E M Kelly, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 3, 2011
Indirect sympatholytic actions at β-adrenoceptors account for the ocular hypotensive actions of cannabinoid receptor agonistsBrian D Hudson, Meggie Beazley, Anna-Maria Szczesniak, et al.
Pageof 11